General Information of Drug (ID: DMC87DR)

Drug Name
GLPG-0259 Drug Info
Synonyms G-13919, GT-146, GT-1498, GT-1704, GT-314, GT-416, GT-514, GT-562
Indication
Disease Entry ICD 11 Status REF
Rheumatoid arthritis FA20 Discontinued in Phase 2 [1]
Cross-matching ID
PubChem CID
44462738
CAS Number
CAS 1195065-29-2
TTD Drug ID
DMC87DR

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID17480064C16 DM4IABG Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MAPK-activated protein kinase 5 (MAPKAPK5) TT3UJ7Z MAPK5_HUMAN Inhibitor [2]

References

1 Clinical pipeline report, company report or official report of Galapagos.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2096).
3 Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). J Med Chem. 2007 May 31;50(11):2647-54.